Patents Assigned to Rijksuniversiteit Te Utrecht
  • Patent number: 5154923
    Abstract: A polypeptide having amino acid sequence 172-192 of a Mycobacterium bovis BCG 64 kD polypeptide, said sequence having the formula ##STR1## as well as polypeptides derived therefrom, in the amino acid sequence of which sequence 172-179 and/or sequence 189-192 is (are) entirely or partially absent, were found to be useful as immunogens inducing resistance to auto-immune arthritis and similar auto-immune diseases.The invention relates to these polypeptides, to polypeptides showing sequential homology with these polypeptides, and to derivatives and multimers thereof. Also, microorganisms expressing the polypeptides either as such or as part of a fusion protein or as a multimer form part of the invention.Finally, the invention relates to pharmaceutical compositions, diagnostic compositions and test kits comprising a compound according to the invention.
    Type: Grant
    Filed: December 21, 1988
    Date of Patent: October 13, 1992
    Assignees: De Staat Der Nederlanden Vertegenwoordigd Door de Minister Van Welzijn, Volksgezondheid En Cultuur, Rijksuniversiteit Te Utrecht, Yeda Research and Development Co. Ltd.
    Inventors: Willem Van Eden, Johannes D. A. Van Embden, Ruurd Van der Zee, Irun R. Cohen